Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ithmaar Holding B.S.C Proxy Solicitation & Information Statement 2026

Mar 5, 2026

66396_rns_2026-03-05_f93fb64f-050f-4552-9e8d-7924d2ab7513.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

==> picture [595 x 95] intentionally omitted <==

PROXY TO ATTEND THE ANNUAL ORDINARY GENERAL MEETING OF ITHMAAR HOLDING B.S.C. (THE "COMPANY")

I, _______ the undersigned, being a shareholder of the Company do hereby appoint _______, holder of ID / Commercial Registration No. ______ (the “ Appointed Proxy ”) to represent and vote on my behalf at the Company’s Annual Ordinary General Meeting (the “ Meeting ”). The Meeting will be held on Sunday, 29 March 2026, commencing at 1:00 pm at Noble Meeting Room, The Westin City Centre Bahrain Hotel, Seef District, Kingdom of Bahrain.

In the event that the quorum for the Meeting is not achieved, a second Meeting will be held on Sunday, 5 April 2026 at the same time and in the same venue. In the event that the quorum for the second Meeting is not achieved, a third Meeting will be held on Sunday, 12 April 2026 at the same time and in the same venue, regardless of the number of the Shareholders who will be in attendance.

The Appointed Proxy is authorized to vote on my behalf with respect to the following:

Agenda of the Annual Ordinary General Meeting Yes No Abstain
1. To receive and approve the minutes of the Ordinary General Meeting
of the Company held on 26 March 2025.
2. To discuss and approve the Directors’ Report on the Company’s
business and financial position for the financial year ended 31
December 2025.
3. To receive the Sharia Supervisory Board’s Report on the Company’s
business for the financial year ended 31 December 2025.
4. To receive the External Auditors’ Report on the Company’s
Consolidated Financial Statements for the financial year ended 31
December 2025.
5. To discuss and approve the Company’s Consolidated Financial
Statements for the financial year ended 31 December 2025.
6. To approve the Board of Directors’ recommendation of the following
allocations, subject to obtaining the approvals of the relevant
governmental and regulatory authorities:
a. Transfer the amount of approximately USD 112,000 to the
statutory reserves; and
b. Transfer the amount of approximately USD 1,009,000 to
the accumulated losses.

1

==> picture [595 x 95] intentionally omitted <==

  1. To report the transactions during the financial year ended 31 December 2025, with any related parties or major shareholders, as stated in Note No. 32 of the financial statements in accordance with Article 189 of the Bahrain Commercial Companies Law No. 21 for the year 2001 and its amendments (“ BCCL ”).

  2. To discuss and approve the Board of Directors report on the Company’s Corporate Governance for the financial year ended 31 December 2025 and the Company’s compliance with the requirements of the Central Bank of Bahrain (“ CBB ”) and the BCCL.

  3. To discharge the Board of Directors of the Company from any liability resulting from the performance of their respective duties during the financial year ended 31 December 2025.

  4. To review and approve the aggregate benefits and remuneration of the members of the Sharia Supervisory Board for the financial year ending 31 December 2026.

  5. To adopt the Board of Directors’ recommendation to appoint the external auditors of the Company for the financial year ending 31 December 2026, subject to the approval of the CBB, and to authorize the Board of Directors to determine their remuneration accordingly.

  6. Any other matters arising in accordance with Article 207 of the BCCL.

Name of Shareholder: ID / Commercial Registration Number: Number of Shares: Percentage: Signature: Date: Contact Number:

2

==> picture [595 x 95] intentionally omitted <==

Notes:

  • (a) Each Shareholder, regardless of the number of the shares he or she owns, shall have the right to attend the Meeting, and shall have a number of votes equal to the number of shares he or she owns in the Company. Any provision or decision to the contrary shall be null and void (Article 203 of the BCCL).

  • (b) Any Shareholder may appoint a proxy to attend the Meeting on their behalf, provided that the proxy holder shall not be the Chairman of the Board of Directors, a Director serving on the Board of Directors or an employee of the Company. However, this shall not prejudice the right to delegate a first-degree relative. This shall be by virtue of a special proxy evidenced in writing designated for this purpose by the Company. Legal representatives of Shareholders lacking capacity or under legal incapacity shall represent them in the Meeting (Article 203 of the BCCL).

  • (c) Shareholders intending to appoint a proxy to represent them at the Meeting are requested to present the proxy form to KFin Technologies (Bahrain) W.L.L. (“ KFin Technologies ”) (on [email protected]) no later than 24 hours prior to the time of the Meeting (Article 203 of the BCCL). Proxy forms may be obtained electronically from the Company’s website www.ithmaarholding.com, Bahrain Bourse website or Dubai Financial Market website.

  • (d) The Directors’ Report and the Consolidated Financial Statements of the financial year ended on 31 December 2025 may be obtained electronically from the Company's website www.ithmaarholding.com, Bahrain Bourse website or Dubai Financial Market website.

  • (e) For any inquiries, please do not hesitate to contact ‘Investor Relations’ on 17585094 or at [email protected].

Disclaimer:

The Appointed Proxy confirms that, by virtue of the Shareholder submitting this proxy form, the Shareholder on whose behalf the Appointed Proxy is attending is not deceased, as at the date of proxy submission. This proxy form is deemed invalid if presented to the Company following the death of the Shareholder.

3